Answers from the Lab

Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.

(01:14)
Could you give us a brief overview of this assay?
 
(02:06)
Can you explain the differences of the qualitative and quantitative methods and why we made the change to a quantitative adenovirus method?
 
(04:00)
When is this test typically ordered for transplant patients? Is it used throughout their treatment?
 
(06:56)
Could an immunocompromised person be unknowingly infected?
 
(07:31)
Is our quantitative method approved for pediatric patients?
 
(08:00)
How are the test results used to treat patients?

(10:36)
What other infections might providers consider alongside adeovirus?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.